文献速递淋巴瘤造血干细胞移植与细胞治疗

理性工程化Notch1信号增强CD19-BBζ CAR-T增殖

Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T.
PubMed 文献 · Blood · 2026-09-02

靶向CD19的CAR-T治疗复发/难治B细胞恶性肿瘤后约50%患者复发,CD19+复发与CAR-T增殖和/或持久性差相关。研究通过调控Notch1(过表达N1ICD或敲除均损害CAR-T活化与增殖),删除内源性N1ICD的PEST结构域以延长信号,使CAR-T活化后增殖增强、体外细胞毒性增加,并在B-ALL异种移植模型中肿瘤减少和CAR-T扩增增加。

要点

  • Notch1信号需精确平衡,过表达或敲除均损害CAR-T活化与增殖。
  • 删除内源性N1ICD的PEST结构域可增强CAR-T活化后增殖和体外抗CD19肿瘤细胞毒性。
  • 在B-ALL异种移植模型中,Notch1 PEST缺失CAR-T较对照肿瘤减少更多且CAR-T扩增增加。

核心结论

  • Notch1在CAR-T效应功能中起关键作用,删除内源性N1ICD的PEST结构域可通过利用天然基因调控增强Notch1活性。

研究设计与样本

  • 研究采用CAR-T细胞基因修饰(Notch1过表达、敲除及PEST结构域删除)结合体外功能实验和B-ALL异种移植体内模型。

主要发现

  • 慢病毒过表达Notch1胞内域(N1ICD)和Notch1基因敲除均导致CAR-T细胞活化和增殖缺陷。
  • Notch1 PEST缺失CAR-T细胞活化后增殖增强,体外对CD19+肿瘤细胞毒性增加。
  • 转录上,Notch1 PEST缺失在CAR活化期间上调干扰素反应通路和增殖基因。
  • 在B-ALL异种移植体内模型中,Notch1 PEST缺失CAR-T较对照CAR-T肿瘤减少更多且CAR-T扩增增加。

临床怎么用

  • 通过删除内源性N1ICD的PEST结构域增强Notch1信号,可能改善CD19-CAR-T的增殖和抗肿瘤效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CAR T-cells targeting CD19 have revolutionized the treatment of relapsed/refractory B-cell malignancies. However, approximately 50% of patients relapse. Patient-derived data indicates that CD19+ relapse is linked to poor CAR T-cell proliferation and/or persistence. We aimed to improve CD19-CAR T-cell survival by manipulating Notch1, a receptor that is activated following T-cell receptor ligation and is essential for upregulating pro-inflammatory and survival genes in T-cells. However, its role in the context of CAR T-cells remains poorly understood. We found that both lentiviral overexpression of Notch1's intracellular domain (N1ICD) and Notch1 genetic knockout resulted in defective CAR-T cell activation and proliferation. This suggests that CAR T-cells require a precise, balanced level of Notch1 signaling for strong effector function. The PEST domain, located at the most distal C-terminus of the Notch1 intracellular domain, regulates the receptor's half-life through ubiquitylation. To augment the levels of active Notch1 and prolong the receptor's signaling, we genetically deleted this domain in the endogenous N1ICD of CAR T-cells. Notch1 PEST-deleted CAR T-cells showed enhanced proliferation post-activation, leading to increased cytotoxicity against CD19+ tumors in vitro. Transcriptionally, Notch1 PEST deletion resulted in upregulation of interferon response pathways and proliferative genes during CAR activation, consistent with Notch1 activation. In B-ALL xenograft in vivo models, treatment with Notch1 PEST-deleted CAR T-cells resulted in greater tumor reduction and increased CAR-T expansion compared to control CAR T-cells. Our findings demonstrate a critical role of Notch1 in CAR-T effector function and provide a novel strategy to augment endogenous Notch1 activity by leveraging native gene regulation.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Phillips MK, Birocchi F, Korell F, et al. Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T. Blood. 2026. PMID: 42684989. doi:10.1182/blood.2026033694

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。